Literature DB >> 14512553

Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.

Marcus Padow1, Lilin Lai, Champion Deivanayagam, Lawrence J DeLucas, Robert B Weiss, Diane M Dunn, Xiaoyun Wu, John C Kappes.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) integrase (IN) protein augments the initiation of reverse transcription. Chimeric HIV-1 containing HIV-2 IN (SG3(IN2)) is severely impaired in virus infectivity and DNA synthesis. To analyze the nature of this defect, we infected T cells with the chimeric SG3(IN2) virus and by continuous passage in cell culture selected for virus with improved replication properties. Viruses from two different time points were chosen for further analysis, an early culture-adapted virus (CF-65) that exhibited an intermediate level of infectivity, and a later-passaged virus (CF-131) that was significantly more infectious. Sequence analysis of multiple clones derived from the CF-65 virus culture demonstrated a diversity of mutations in the reverse transcriptase (RT) and a common V204I IN mutation. Analysis of clones derived from the CF-131 virus indicated the selection of two additional IN mutations, Q96H and K127E, and a fixed V179I RT mutation. By cloning RT and/or IN sequences back into the original SG3(IN2) chimeric virus, we demonstrated that mutations in both RT and IN contributed to the improvement in viral fitness. The effect of the HIV-2IN(IN(2)) mutations on virus DNA synthesis was analyzed by packaging IN(2) mutants into HIV-1 as Vpr-IN(2) fusion proteins. This analysis revealed that the Q96H, K127E and V204I mutations increased the infectivity of the chimeric virus by augmenting the initiation of viral cDNA synthesis in infected cells. The Q96H and K127E mutations are present in adjacent helical structures on the surface of the IN protein and together account for most of the increase observed in DNA synthesis. Our findings provide evidence that the IN protein augments the initiation of reverse transcription through specific interactions with other viral components comprising the initiation complex. Moreover, they implicate specific regions on the surface of IN that may help to elucidate mechanisms by which the HIV-1 IN protein augments the initiation of HIV-1 reverse transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512553      PMCID: PMC224969          DOI: 10.1128/jvi.77.20.11050-11059.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.

Authors:  M H Nymark-McMahon; S B Sandmeyer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.

Authors:  N Tsurutani; M Kubo; Y Maeda; T Ohashi; N Yamamoto; M Kannagi; T Masuda
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.

Authors:  L Lai; H Liu; X Wu; J C Kappes
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.

Authors:  T Masuda; V Planelles; P Krogstad; I S Chen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.

Authors:  A D Leavitt; G Robles; N Alesandro; H E Varmus
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.

Authors:  X Wu; H Liu; H Xiao; J Kim; P Seshaiah; G Natsoulis; J D Boeke; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  Complementation between HIV integrase proteins mutated in different domains.

Authors:  D C van Gent; C Vink; A A Groeneger; R H Plasterk
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  10 in total

Review 1.  The diversity of retrotransposons and the properties of their reverse transcriptases.

Authors:  Thomas H Eickbush; Varuni K Jamburuthugoda
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

2.  Primitive hematopoietic cells resist HIV-1 infection via p21.

Authors:  Jielin Zhang; David T Scadden; Clyde S Crumpacker
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Cooperation between reverse transcriptase and integrase during reverse transcription and formation of the preintegrative complex of Ty1.

Authors:  Marcelle Wilhelm; F-X Wilhelm
Journal:  Eukaryot Cell       Date:  2006-10

4.  Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1.

Authors:  M Wilhelm; F-X Wilhelm
Journal:  Eukaryot Cell       Date:  2005-06

5.  Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Alok Mulky; Stefan G Sarafianos; Edward Arnold; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase.

Authors:  Thomas A Wilkinson; Kurt Januszyk; Martin L Phillips; Shewit S Tekeste; Min Zhang; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Biol Chem       Date:  2009-01-16       Impact factor: 5.157

7.  Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells.

Authors:  Jin H Kim; Hanna Song; Jamie L Austin; Wei Cheng
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir.

Authors:  Danielle Perez Bercoff; Perrine Triqueneaux; Christine Lambert; Aboubacar Alassane Oumar; Anne-Marie Ternes; Sounkalo Dao; Patrick Goubau; Jean-Claude Schmit; Jean Ruelle
Journal:  Retrovirology       Date:  2010-11-29       Impact factor: 4.602

Review 9.  The Vpr protein from HIV-1: distinct roles along the viral life cycle.

Authors:  Erwann Le Rouzic; Serge Benichou
Journal:  Retrovirology       Date:  2005-02-22       Impact factor: 4.602

10.  Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity.

Authors:  Jonathan M O Rawson; Olga A Nikolaitchik; Brandon F Keele; Vinay K Pathak; Wei-Shau Hu
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.